Name: Medical Digest
Author: Medical Digest

風濕免疫科5 篇

影響力 2

Interleukin-2 is associated with cytopenias in systemic lupus erythematosus.

發表日期: 2026-12-31

Autoimmunity

Medical Digest 收錄日: 2026-07-27

This study involving 235 patients with systemic lupus erythematosus (SLE) found that lower serum interleukin-2 (IL-2) levels were associated with specific hematological abnormalities, including anemia, leukopenia, and lymphopenia. Using multivariate regression analysis, the study identified signi...

在PubMed上閱讀

影響力 2

Probiotic

發表日期: 2026-12-31

Gut microbes

Medical Digest 收錄日: 2026-07-24

This study highlights the role of gut microbiota dysbiosis and host protein glycosylation in the immune signaling involved in the progression of rheumatoid arthritis (RA).

在PubMed上閱讀

影響力 1

Clinicopathological Features of Lupus Erythematosus Panniculitis (LEP): A Retrospective Analysis of 54 Cases.

發表日期: 2026-08-01

Health science reports

Medical Digest 收錄日: 2026-07-28

(Summary generation failed. Please refer to the original article.)

在PubMed上閱讀

影響力 1

Multi-omics profiling characterizes the primary cilium-related molecular regulatory landscape in systemic lupus erythematosus.

發表日期: 2026-07-27

The Analyst

Medical Digest 收錄日: 2026-07-29

(No abstract provided)

在PubMed上閱讀

影響力 1

Wedelolactone alleviates rheumatoid arthritis by gut microbiota-dependent immunomodulation and p53-mediated inhibition of fibroblast-like synoviocytes.

發表日期: 2026-07-25

Phytomedicine : international journal of phytotherapy and phytopharmacology

Medical Digest 收錄日: 2026-07-26

(Summary generation failed. Please refer to the original article.)

在PubMed上閱讀

醫學研究趨勢

風濕免疫科5 篇

Interleukin-2 is associated with cytopenias in systemic lupus erythematosus.

Probiotic

Clinicopathological Features of Lupus Erythematosus Panniculitis (LEP): A Retrospective Analysis of 54 Cases.

Multi-omics profiling characterizes the primary cilium-related molecular regulatory landscape in systemic lupus erythematosus.

Wedelolactone alleviates rheumatoid arthritis by gut microbiota-dependent immunomodulation and p53-mediated inhibition of fibroblast-like synoviocytes.

獲取個人化每日摘要